tb 500 and bpc 157 pills regenmed direct peptides bpc-157 tb-500 Regeno Blend (BPC-157, TB-500, Cartalax) 30mg BPC-157 / TB-500 Capsules BPC-157 and TB-500 Blend —

It is intended exclusively as a diluent or reconstitution medium for other research compounds

For higher dosages, please consult your healthcare provider

Following a vegan or vegetarian diet, having gastrointestinal issues, having pernicious anemia, and taking specific drugs are issues that frequently result in a deficiency

These tissues can sometimes be slow to recover, particularly when blood flow is limited

BENEFITS Triple receptor activation studied for simultaneous GLP-1, GIP, and glucagon engagement Metabolic research explored in Phase 2 clinical trials with notable body-composition results Glucagon component linked to thermogenesis and energy-expenditure pathways Next-generation compound investigated as an advancement over dual-agonist approaches Comparative pharmacology assessed alongside mono- and dual-agonists in research settings WHAT RESEARCHERS LOOK AT Triple-agonist binding affinity across GLP-1, GIP, and glucagon receptors Additive effects of glucagon-receptor activation on energy expenditure Dose-response and tolerability profiling from clinical-trial data Comparative outcomes vs tirzepatide and semaglutide Pharmacokinetic profiling and receptor selectivity QUICK SPECS Form: Lyophilized peptide powder Net per vial: 10 mg Purity: 99% (HPLC verified) Identity: MS-verified (per COA) Storage: 28C, protect from light and moisture Reconstitution: Use bacteriostatic water (sold separately) IDENTITY BASICS CAS: 2381089-83-2 Classification: Triple GLP-1/GIP/glucagon receptor agonist WHY CHOOSE DURHAM PEPTIDES FOR RETATRUTIDE

Do not rub, scratch, or test sharpness on numb areas